Tumorigenicity and Analysis of the Cell Growth of Human Medulloblastoma
Tumorigenicity and Analysis of the Cell Growth of Human Medulloblastoma
批准号:
01570809
负责人:
SHIMIZU Keiji
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Medulloblastoma are among the most common malignant brain tumors in children. It suggested that the precursors of these tumors consisted of immature bipotential cells which could differentiate into neuronal and glial cells. We established two human medulloblastoma cell lines in order to investigate their characterization and cell differentiation. One was derived from a 2-year-old girl with a cerebellar tumor (designated as ONS-76 cells), and another was from a 9-year-old girl with a metastatic tumor in the right lower frontal lobe from her posterior fossa (designated as ONS-81 cells). The in vitro population-doubling times were 18.6 and 19.2 hours, respectively. These cells were transplantable into the nude mice subcutaneously and intrathecally. Experimental models with meningeal dissemination were produced by intracisternal inoculation of ONS-76 cells into the nude mice. All mice were dead within 65 days after 1x107 tumor cells were inoculated intracisternally. Their median survival t … More ime (MST) was 56 days.Immunohistochemical studies showed that both cells possessed neurofilament protein (NFP) (Mr 145 K and 200K) and neuron-specific enolase (NSE), without glial fibrillar acidic protein (GFAP) or S-100 protein. These cell lines also had epidermal growth factor (EGF) receptor (R), Transferrin-R, and lnsulinーR. These cells could grow in the growth medium without fetal calf serum (FCS). Most these cells possessed class I major histocompatibility complex (MHC) antigens, and these class I antigens were able to be enhanced by human interferon-g (IFN-g). Both cell lines didn't have class II MHC antigen, but these antigens could be induced by human IFN-g. ONS-76 and ONS-81 cells expressed proto-oncogene (N-myc and c-src) products. These cells showed drug-induced differentiation under 50-100 mM of dibutyryl cyclic-adenosine 3', 5'-monophosphate (dbt-cAMP). Fluorescence-activated cell sorter (FACScan) analysis also showed that these both cell lines increased expression of pp60^<c-src> products and NFP (145 K and 200 K). A monoclonal antibody (mAb) (ONS-M-1.0) of lgG2 isotype was raised against medulloblastoma by immunization of mice with ONS--76 cells. This mAb bound these two human medulloblastoma (ONS-76 and -81) cells selectively. Natural killer cells were demonstrated a little ONS-M-1.0 antigens. Biochemical analysis showed that these antigens were sensitive to trypsin but not to neuraminidase, and that they were heat-stable. The high specificity of this antibody^* on medullobalstoma cells might be contributory to the diagnostic and therapeutic strategies for medulloblastoma. Less
期刊论文(76)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
山田 正信: "樹立細胞株を用いたPNET及び髄芽腫の生物学的比較検討" 神経免疫研究. 2. 137-142 (1989)
Masanobu Yamada:“使用已建立的细胞系对 PNET 和髓母细胞瘤进行生物学比较研究”《神经免疫学研究》2. 137-142 (1989)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
清水 恵司: "脳腫瘍患者に対する養子免疫療法の長期追跡結果" Biotherapy. 4. 478-482 (1990)
Keiji Shimizu:“脑肿瘤患者过继免疫治疗的长期随访结果”生物治疗 4. 478-482 (1990)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
馬淵 英一郎: "ヒト悪性脳腫瘍に対するin vitro感受性試験" 癌と化学療法. 18. 233-238 (1991)
Eiichiro Mabuchi:“人类恶性脑肿瘤的体外敏感性试验”《癌症与化疗》18. 233-238 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada M, Shimizu K, et al: "Establishment and biological characterization of human medulloblastoma and PNET cell lines." Neuroimmunol. Res.2. 137-142 (1989)
Yamada M、Shimizu K 等人:“人髓母细胞瘤和 PNET 细胞系的建立和生物学特性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
清水恵司: "髄芽種患者に対する養子免疫療法" 脳と神経. 41. 991-995 (1989)
Keiji Shimizu:“髓母细胞瘤患者的过继免疫疗法”《大脑和神经》41. 991-995 (1989)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 53 条
Effect of abnormalities in asymmetric cell divisions of neural stem cells on brain tumor initiation
-
批准号:23659690
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:SHIMIZU Keiji
-
依托单位:
New therapeutic strategies for malignant brain tumors by using genetic and molecular biology
-
批准号:16390411
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2004
-
负责人:SHIMIZU Keiji
-
依托单位:
Basic research of malignant glioma-specific gene therapy by using very high titer retrovirus vectors
-
批准号:12470290
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2000
-
负责人:SHIMIZU Keiji
-
依托单位:
Development for new transduction of gene by using mouse monoclonal antibody or its humanized antibody
-
批准号:08457363
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1996
-
负责人:SHIMIZU Keiji
-
依托单位:
Moleculo-biological analysis for mechanism of proliferation and differentiation in glioma cells and its clinical application
-
批准号:04454360
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.58万
-
财政年份:1992
-
负责人:SHIMIZU Keiji
-
依托单位:
Immunological conditions of patients with malignant gliomas ---Therapeutic drugs and Selection of BRMs---
-
批准号:62570656
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1987
-
负责人:SHIMIZU Keiji
-
依托单位:
Identity and their origins of immune cells in the brain
-
批准号:60570671
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.96万
-
财政年份:1985
-
负责人:SHIMIZU Keiji
-
依托单位:
海外基金